Financial Performance of Pharmaceutical Industry in India

Surender Kumar, Abhijit Nair, Ritika Gugnani

Abstract


The performance measurement of companies has been the subject of numerous surveys during the last few years. In the present study, the Data Envelopment Analysis (DEA) technique as well as the financial-based variables such as Current Ratio,  Quick Ratio, Debt Equity Ratio are taken as input indicators and  Gross Profit Margin (%), Net Profit Margin (%), Return on Assets Including Revaluations, Dividend Per Share, Earnings Per Share (EPS), D/P Ratio (Dividend Pay-out Ratio) as Output Indicatorshave been applied to measure the performance and efficiency ofthe selected pharmaceutical companies during the period of  2013-2014 to 2016-2017. The main objective of this research is to analysis pharmaceutical companies and comparing their efficiency by data envelopment analysis (DEA). In this work we have used an integrated fundamental analysis and DEA model to analyse the pharmaceutical sector. 


Keywords


Indian pharmaceutical Industry, MarketShare, Growth, Efficiency, Data envelopment analysis

Full Text:

PDF

References


Andersen P & Petersen NC (1993).A Procedure for Ranking Efficient Units in Data Envelopment Analysis. Management Science 39 1261-1264. 2. Bowlin WF (1998).Measuring Performance: An Introduction to Data Envelopment Analysis (DEA). Journal of Cost Analysis 7 3-27. 3. Charnes A, Cooper W & Rhodes E (1978). Measuring the Efficiency of Decision Making Units. European Journal of Operational Research 2 429-444. 4. Doyle JT, Lundholm RJ &Soliman MT (2003). The predictive value of expenses excluded from ‘Pro Forma’ earnings.Review of Accounting Studies 8 145-174. 5. Emrouznejad A, Parker B & Tavares G (2008). Evaluation of research in efficiency and productivity: A survey and analysis of the first 30 years of scholarly literature in DEA. 6. Socio-Economic Planning Sciences 42(3) 151-157. 7. Greene W (2010). The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market,(U. S. International Trade Commission Washington D.C. USA).

Panchal M, Kapoor C &Mahajan M (2014).Success strategies for Indian pharma industry in an uncertain world.Business Standard. 9. Piotroski JD (2000). Value investing: The use of historical financial statement information to separate winners from losers. Journal of Accounting Research38 1-41. 10. Seetharaman R & Narayanan R (2013).A Research Project on Fundamental Analysis of Pharma Sector. (SRM University). 11. Thanassoulis E (2001). Introduction to the Theory and Application of Data Envelopment Analysis: A Foundation Text with Integrated Software,(U.S., Boston: Kluwer Academic Publisher). 12. Thomsett MC (1998).Mastering Fundamental Analysis,(Illinois, Chicago: Dearborn Financial Publication). 13. Times E (2010). Indian biotech industry grew 17 percent in 2009-10: Survey. Economic Times. Available: www. bse.com.(n.d.).


Refbacks

  • There are currently no refbacks.